Edition:
United Kingdom

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

3.65USD
20 Sep 2018
Change (% chg)

$-0.26 (-6.65%)
Prev Close
$3.91
Open
$3.90
Day's High
$3.90
Day's Low
$3.65
Volume
20,343
Avg. Vol
23,286
52-wk High
$7.27
52-wk Low
$2.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 31.90 -1.667
Mar '18 27.48 -1.755
FY 2017 Dec '17 38.91 -1.316
Sep '17 28.67 -2.668
Jun '17 40.88 -1.152
Mar '17 29.98 -1.670
FY 2016 Dec '16 13.57 -1.482
Sep '16 0.00 -0.562
Jun '16 0.00 -0.485
Mar '16 0.00 -2.072
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 35.15 36.10 34.20 --
Quarter Ending Dec-18 2 42.40 43.60 41.20 --
Year Ending Dec-18 2 136.95 137.20 136.70 160.65
Year Ending Dec-19 2 167.60 187.90 147.30 189.20
Earnings (per share)
Quarter Ending Sep-18 2 -0.71 0.07 -1.49 --
Quarter Ending Dec-18 2 -0.56 0.16 -1.27 --
Year Ending Dec-18 2 -4.69 -3.20 -6.18 -1.21
Year Ending Dec-19 2 -2.53 1.30 -6.35 -0.43
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 107.68 32.65
P/E High - Last 5 Yrs. -- 279.69 47.28
P/E Low - Last 5 Yrs. -- 98.16 24.79
Beta 0.90 0.62 0.87
Price to Sales (TTM) 0.58 108.66 6.44
Price to Book (MRQ) -- 12.37 3.90
Price to Tangible Book (MRQ) -- 18.63 5.95
Price to Cash Flow (TTM) -- 61.73 23.45
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.70
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.63 -5.68
Payout Ratio(TTM) -- 5.94 46.50

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -21.95 176.86 8.40
Sales (TTM) vs TTM 1 Yr. Ago 50.37 93.42 6.69
Sales - 5 Yr. Growth Rate -- 24.48 7.57
EPS (MRQ) vs Qtr. 1 Yr. Ago -44.67 282.99 25.61
EPS (TTM) vs TTM 1 Yr. Ago -52.18 -- --
EPS - 5 Yr. Growth Rate -- 23.63 7.61
Capital Spending - 5 Yr. Growth Rate -3.31 38.58 8.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.13 1.62 2.20
Current Ratio (MRQ) 1.33 5.44 2.97
LT Debt to Equity (MRQ) -- 15.00 11.19
Total Debt to Equity (MRQ) -- 18.46 14.01
Interest Coverage (TTM) -2.33 -201.28 35.20

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 40.37 56.05 54.65
Gross Margin - 5 Yr. Avg. -- 52.69 53.29
EBITD Margin (TTM) -51.66 -- --
EBITD - 5 Yr. Avg -118.62 -175.26 15.94
Operating Margin (TTM) -73.04 -602.86 3.76
Operating Margin - 5 Yr. Avg. -117.86 -188.80 11.06
Pre-Tax Margin (TTM) -107.81 -599.74 4.08
Pre-Tax Margin - 5 Yr. Avg. -151.93 -191.11 11.25
Net Profit Margin (TTM) -109.01 -594.93 0.80
Net Profit Margin - 5 Yr. Avg. -152.90 -188.77 7.58
Effective Tax Rate (TTM) -- 11.62 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.25 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 705,361 5,194,301 714,438,801
Net Income/Employee (TTM) -768,900 -5,791,431 82,488,037
Receivable Turnover (TTM) 7.98 5.37 5.03
Inventory Turnover (TTM) 3.93 2.07 3.60
Asset Turnover (TTM) 0.33 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -35.46 0.82 9.74
Return on Assets - 5 Yr. Avg. -17.40 2.59 10.91
Return on Investment (TTM) -45.79 1.61 12.72
Return on Investment - 5 Yr. Avg. -19.90 2.07 14.03
Return on Equity (TTM) -657.09 0.32 14.84
Return on Equity - 5 Yr. Avg. -29.31 -2.31 15.38
  1 Year 3 Year 5 Year
Sales % 919.88 -- --
EPS (TTM) % -45.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novelion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.32 23.33 91 74
13 Week 2.89 -2.08 68 50
26 Week 9.83 2.43 68 44
52 Week -43.25 -51.08 22 88
YTD 25.32 15.22 75 82
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.01%
# of Holders: 66
Total Shares Held: 15,649,428
3 Mo. Net Change: 94,210
# New Positions: 8
# Closed Positions: 37
# Increased Positions: 17
# Reduced Positions: 53
# Net Buyers: -36
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.